IFP Exclusive

Nano Pharmaceutical Developed to Target Cancer Cells

An Iranian knowledge-based company has managed to develop a nano-pharmaceutical that targets cancerous cells and helps treat recurrent cancers.

Drugs used to treat cancer are mainly divided into biological and chemical ones. In the biological treatment, which is a common cancer treatment, cancerous tissue is targeted. However, by using nanotechnology, the nano-particles take responsibility for transporting albumin into the cancerous cell.

This increases the quality, the speed of drug distribution, and the effectiveness of the medicine. This system is especially effective for the cancers that have undergone a course of treatment and are recurrent.

Nanodarou Company was founded with a small investment as a knowledge-based firm by the students and professors of Tehran University of Medical Sciences in 2011, when the Resistance Economy was introduced and recommended by the Leader of Iran’s Islamic Revolution.

The difficulty was that no imported or domestic samples of this drug were available. Despite many complications, the drug entered the market in 2016. Within three months, it was also sold in Turkey. It is now known to be the definitive medication for recurrent cancer. The production of these drugs requires a safe environment for the workers which is provided by the company.

It is currently used to treat metastatic breast cancer, pancreatic cancer, lung cancer, ovarian cancer and stomach cancer. The main purpose of producing these drugs is to increase the patient’s life and improve his/her quality of life during the course of treatment. It means that despite the illness, there is no pain in these diseases, and the patient can have normal life.

For a brief review of Iran’s achievements in various fields of science and technology, check the book “Science and Technology in Iran: A Brief Review

Another product of this company is the addiction treatment drug that is produced by macrospheric technique (spherical particles) and injected deep into the body of the patient and continuously released in a patient’s body within a month.

In this way, the need for the opiate disappears and the receptors of pleasure fail, and ultimately it is fully treated between 6 and 24 months.

In the past year, 8,000 doses of these drugs have been consumed; and about half of them have been sold in Turkish markets.

These medications are currently exported to five countries of the world, and nine other countries will receive them as soon as possible.

The Nanodarou Company will be present at the 2018 International Nanotechnology Exhibition, which will be held from October 13 to 16 in the Iranian capital Tehran.

Seyedeh Maryam Hosseini Lahijani

Hedieh Lahiji is an Iranian journalist who mainly reports the latest developments in science and technology. Her work in the IFP is mainly focused on the coverage of Iranian knowledge-based companies and their scientific achievements.

Recent Posts

“Iran Hamdel” campaign sends aid to Gaza amid war

Aid items donated by millions of Iranians within a national campaign, have reached the beseiged…

6 hours ago

Iranian deputy FM: Cooperation with Saudis serves as a successful model for fostering peace and security

Iran's Deputy Foreign Minister Majid Takht Ravanchi has said Iran and Saudi Arabia are committed…

6 hours ago

Official: Iran responds to IAEA resolution with increased nuclear enrichment capacity

Behrouz Kamalvandi, the spokesperson for the Atomic Energy Organization of Iran (AEOI), says the organization…

7 hours ago

Pictures: Demonstrators in Tehran support people of Gaza, Lebanon

Hundreds of people gathered in Tehran on Friday morning in front of the United Nations…

7 hours ago

Int’l lawyer: US plans to sanction countries cooperating with ICC on Netanyahu arrest

An international law expert and analyst has revealed the U.S. plans to impose punitive measures…

10 hours ago

Minister of science: 25% of Iranian university professors emigrated due to economic challenges

Iran’s Minister of Science, Research, and Technology, Hossein Simayee Saraf, addressed on Thursday academic migration…

10 hours ago